Clinical Trial Update: Radiofrequency Ablation (RFA) Versus Antiarrhythmic Drug Treatment in Paroxysmal Atrial Fibrillation [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing radiofrequency ablation to antiarrhythmic drug therapy for paroxysmal atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Paroxysmal Atrial Fibrillation

Snippet

Sponsor: Danish Heart Foundation | Conditions: Atrial Fibrillation | Phase 3 | Status: COMPLETED